85 related articles for article (PubMed ID: 16283030)
1. [Therapy of advanced heart failure adapted to hemodynamic objectives acquired by invasive hemodynamic monitoring].
Almeida Júnior GL; Esporcatte R; Rangel FO; Rocha RM; Gouvêa e Silva Gde M; Tura BR; Jorge JK; Drumond LE; Albanesi Filho FM
Arq Bras Cardiol; 2005 Oct; 85(4):247-53. PubMed ID: 16283030
[TBL] [Abstract][Full Text] [Related]
2. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure.
Johnson W; Omland T; Hall C; Lucas C; Myking OL; Collins C; Pfeffer M; Rouleau JL; Stevenson LW
J Am Coll Cardiol; 2002 May; 39(10):1623-9. PubMed ID: 12020489
[TBL] [Abstract][Full Text] [Related]
3. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH
Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945
[TBL] [Abstract][Full Text] [Related]
4. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
[TBL] [Abstract][Full Text] [Related]
5. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
[TBL] [Abstract][Full Text] [Related]
6. Early and medium term results of tailored therapy for heart failure.
Martins S; Soares RM; do Rosário L; Quininha J; Antunes AM
Rev Port Cardiol; 2001 Mar; 20(3):261-82. PubMed ID: 11417309
[TBL] [Abstract][Full Text] [Related]
7. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
8. Refractory acute decompensated heart failure: an observational study on a noninvasive hemodynamic monitoring system aimed at improving the therapeutic approach.
Frea S; Franco E; Najd K; Panella S; Pinneri F
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):655-61. PubMed ID: 20308915
[TBL] [Abstract][Full Text] [Related]
9. Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure.
Ishihara S; Gayat E; Sato N; Arrigo M; Laribi S; Legrand M; Placido R; Manivet P; Cohen-Solal A; Abraham WT; Jessup M; Mebazaa A
Clin Res Cardiol; 2016 Dec; 105(12):971-980. PubMed ID: 27314418
[TBL] [Abstract][Full Text] [Related]
10. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
[TBL] [Abstract][Full Text] [Related]
11. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
12. Sodium Nitroprusside in Patients With Mixed Pulmonary Hypertension and Left Heart Disease: Hemodynamic Predictors of Response and Prognostic Implications.
Lim HS; Zaphiriou A
J Card Fail; 2016 Feb; 22(2):117-24. PubMed ID: 26547011
[TBL] [Abstract][Full Text] [Related]
13. Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction.
Eleid MF; Nishimura RA; Sorajja P; Borlaug BA
Circulation; 2013 Sep; 128(12):1349-53. PubMed ID: 23956211
[TBL] [Abstract][Full Text] [Related]
14. [Hemodynamic guidelines in the treatment of acute myocardial infarction by means of vasodilators].
Zilcher H
Acta Med Austriaca Suppl; 1979; 15():1-34. PubMed ID: 161946
[TBL] [Abstract][Full Text] [Related]
15. Implications of the hemodynamic optimization approach guided by right heart catheterization in patients with severe heart failure.
Rohde LE; Furian T; Campos C; Biolo A; Rabelo E; Foppa M; Clausell N
Arq Bras Cardiol; 2002 Mar; 78(3):261-6. PubMed ID: 11967581
[TBL] [Abstract][Full Text] [Related]
16. Early right ventriculo-arterial uncoupling in borderline pulmonary hypertension on experimental heart failure.
Pagnamenta A; Dewachter C; McEntee K; Fesler P; Brimioulle S; Naeije R
J Appl Physiol (1985); 2010 Oct; 109(4):1080-5. PubMed ID: 20689091
[TBL] [Abstract][Full Text] [Related]
17. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
18. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic response to intensive unloading therapy (furosemide and nitroprusside) in patients >70 years of age with left ventricular systolic dysfunction and decompensated chronic heart failure.
Cioffi G; Stefenelli C; Tarantini L; Opasich C
Am J Cardiol; 2003 Nov; 92(9):1050-6. PubMed ID: 14583355
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
Dei Cas L; Fappani A; Riva S; Metra M; Cicogna R; Manca C; Visioli O
Clin Cardiol; 1985 Aug; 8(8):427-32. PubMed ID: 4028536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
